Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Savara Pharmaceuticals (SVRA) has a market cap of $0.51 billion USD. According to our data, Savara Pharmaceuticals is ranked No.5955 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.51 B |
-4.00%
|
| Dec 31, 2024 | $0.53 B |
-34.68%
|
| Dec 29, 2023 | $0.81 B |
203.23%
|
| Dec 30, 2022 | $0.27 B |
25.00%
|
| Dec 31, 2021 | $0.21 B |
7.83%
|
| Dec 31, 2020 | $0.20 B |
-74.33%
|
| Dec 31, 2019 | $0.77 B |
-40.82%
|
| Dec 31, 2018 | $1.30 B |
-48.99%
|
| Dec 29, 2017 | $2.55 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Insmed
INSM
|
$12.92 B |
-0.000 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
USA
|
 PTC Therapeutics
PTCT
|
$3.70 B |
-0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
USA
|
| Market Cap | = | SVRA Stock Price | * | SVRA Shares Outstanding |
| = | $2.93 | * | 0.17 B | |
| = | $0.51 B |